AMANDA ALONZO: Open Payments
NPI 1982206835 · CHANUTE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 41 payments from 10 companies in 2025. Trend: 2023 $37 · 2024 $1,479 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Alkermes, Inc. | 2 | $48 |
| Tris Pharma Inc | 3 | $46 |
| Corium, LLC | 4 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, Dyanavel XR, Azstarys, Qelbree, Auvelity, SPRAVATO.
Industry payments across KS — which companies pay providers there.
